Article
Targeting Met and Notch in the<i>Lfng</i>-deficient,<i>Met</i>-amplified triple-negative breast cancer
20 Feb 2014
Abstract excerpt
Triple negative breast cancer (TNBC) accounts for 15-20% of breast carcinomas and represents one of the most aggressive forms of this disease. Basal and claudin-low are the two main molecular subtypes among TNBCs. We previously reported that deletion of Lfng in mouse mammary gland caused deregulated Notch activation and induced basal-like and claudin-low tumors with co-selection for Met amplification. In human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
